APA

Fakhrudin N., Waltenberger B., Cabaravdic M., Atanasov A. G., Malainer C., Schachner D., Heiss E. H., Liu R., Noha S. M., Grzywacz A. M., Mihaly-Bison J., Awad E. M., Schuster D., Breuss J. M., Rollinger J. M., Bochkov V., Stuppner H. & Dirsch V. M. (20141112). Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo. : British journal of pharmacology.

Chicago

Fakhrudin N, Waltenberger B, Cabaravdic M, Atanasov A G, Malainer C, Schachner D, Heiss E H, Liu R, Noha S M, Grzywacz A M, Mihaly-Bison J, Awad E M, Schuster D, Breuss J M, Rollinger J M, Bochkov V, Stuppner H and Dirsch V M. 20141112. Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo. : British journal of pharmacology.

Harvard

Fakhrudin N., Waltenberger B., Cabaravdic M., Atanasov A. G., Malainer C., Schachner D., Heiss E. H., Liu R., Noha S. M., Grzywacz A. M., Mihaly-Bison J., Awad E. M., Schuster D., Breuss J. M., Rollinger J. M., Bochkov V., Stuppner H. and Dirsch V. M. (20141112). Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo. : British journal of pharmacology.

MLA

Fakhrudin N, Waltenberger B, Cabaravdic M, Atanasov A G, Malainer C, Schachner D, Heiss E H, Liu R, Noha S M, Grzywacz A M, Mihaly-Bison J, Awad E M, Schuster D, Breuss J M, Rollinger J M, Bochkov V, Stuppner H and Dirsch V M. Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo. : British journal of pharmacology. 20141112.